Rutkowski P - Search Results

1

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.

Schöffski P, Wozniak A, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Gelderblom H, Italiano A, Lindner LH, Hennig I, Strauss S, Zakotnik B, Anthoney A, Albiges L, Blay JY, Reichardt P, Sufliarsky J, van der Graaf WTA, Debiec-Rychter M, Sciot R, Van Cann T, Marréaud S, Raveloarivahy T, Collette S, Stacchiotti S. Schöffski P, et al. Among authors: rutkowski p. Ann Oncol. 2018 Mar 1;29(3):758-765. doi: 10.1093/annonc/mdx774. Ann Oncol. 2018. PMID: 29216400 Free article. Clinical Trial.

2

Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.

Ruka W, Rutkowski P, Kaminska J, Rysinska A, Steffen J. Ruka W, et al. Among authors: rutkowski p. Ann Oncol. 2001 Oct;12(10):1423-32. doi: 10.1023/a:1012527006566. Ann Oncol. 2001. PMID: 11762815 Free article.

3

Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas.

Dziewirski W, Rutkowski P, Nowecki ZI, Sałamacha M, Morysiński T, Kulik A, Kawczyńska M, Kasprowicz A, Lyczek J, Ruka W. Dziewirski W, et al. Among authors: rutkowski p. Ann Surg Oncol. 2006 Feb;13(2):245-52. doi: 10.1245/ASO.2006.03.026. Epub 2006 Jan 17. Ann Surg Oncol. 2006. PMID: 16411144 Clinical Trial.

4

Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs).

Rutkowski P, Nowecki ZI, Debiec-Rychter M, Grzesiakowska U, Michej W, Woźniak A, Siedlecki JA, Limon J, vel Dobosz AJ, Kakol M, Osuch C, Ruka W. Rutkowski P, et al. J Cancer Res Clin Oncol. 2007 Sep;133(9):589-97. doi: 10.1007/s00432-007-0202-4. Epub 2007 Apr 26. J Cancer Res Clin Oncol. 2007. PMID: 17458563

5

Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.

Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Woźniak A, Limon J, Siedlecki J, Grzesiakowska U, Kakol M, Osuch C, Polkowski M, Głuszek S, Zurawski Z, Ruka W. Rutkowski P, et al. Ann Surg Oncol. 2007 Jul;14(7):2018-27. doi: 10.1245/s10434-007-9377-9. Epub 2007 May 2. Ann Surg Oncol. 2007. PMID: 17473953

6

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.

Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W. Rutkowski P, et al. Med Sci Monit. 2007 Nov;13(11):CR515-522. Med Sci Monit. 2007. PMID: 17968300

7

Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation.

Woźniak A, Rutkowski P, Sciot R, Ruka W, Michej W, Debiec-Rychter M. Woźniak A, et al. Among authors: rutkowski p. Int J Cancer. 2008 May 1;122(9):2160-4. doi: 10.1002/ijc.23338. Int J Cancer. 2008. PMID: 18183595 Free article.

8

Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib.

Ruka W, Rutkowski P, Szawłowski A, Nowecki Z, Debiec-Rychter M, Grzesiakowska U, Dziewirski W, Siedlecki JA, Michej W. Ruka W, et al. Among authors: rutkowski p. Eur J Surg Oncol. 2009 Jan;35(1):87-91. doi: 10.1016/j.ejso.2008.01.003. Epub 2008 Mar 4. Eur J Surg Oncol. 2009. PMID: 18289826

9

Gastrointestinal stromal tumors: key to diagnosis and choice of therapy.

Rutkowski P, Debiec-Rychter M, Ruka W. Rutkowski P, et al. Mol Diagn Ther. 2008;12(3):131-43. doi: 10.1007/BF03256278. Mol Diagn Ther. 2008. PMID: 18510377 Review.

10

Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Rutkowski P, Van Glabbeke M, Rankin CJ, Ruka W, Rubin BP, Debiec-Rychter M, Lazar A, Gelderblom H, Sciot R, Lopez-Terrada D, Hohenberger P, van Oosterom AT, Schuetze SM; European Organisation for Research and Treatment of Cancer Soft Tissue/Bone Sarcoma Group; Southwest Oncology Group. Rutkowski P, et al. J Clin Oncol. 2010 Apr 1;28(10):1772-9. doi: 10.1200/JCO.2009.25.7899. Epub 2010 Mar 1. J Clin Oncol. 2010. PMID: 20194851 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

659 results

Search Page